Literature DB >> 2973515

Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency.

M Rubin1, G Karpati, L S Wolfe, S Carpenter, M H Klavins, D J Mahuran.   

Abstract

Two sisters presented with progressive muscle cramps, as well as wasting and weakness of the legs with onset after age 20. They also showed intention tremor of the upper extremities and dysarthria starting during the first decade. The older patient also had fasciculations; the younger, hyperreflexia. Total plasma beta-hexosaminidase (Hex) activity with 4-methylumbelliferyl-acetyl-glucosamine as substrate was reduced to 1.4% and 2.7% of the control in the 2 patients, respectively. Hex A activity measured by 4-methylumbelliferyl-N-acetylglucosamine-6-O-sulphate as substrate was 9.9% and 12.8% of the mean control value in the 2 patients, respectively. Hex B activity was undetectable in both patients. Leukocyte total Hex activity was 7-8% of normal; residual Hex A activity in the 2 patients was 17.8% and 16.3% of normal controls, respectively. Fibroblastic residual Hex A activity in the 2 patients was 9.6% and 22% of normal mean value, respectively. Appendiceal ganglion cells contained membranous cytoplasmic bodies in the younger patient. Thin layer chromatography of the appendiceal extract from one patient (III/2) showed a marked increase of GM2 ganglioside, and some increase of GM3 ganglioside. Northern blots performed on fibroblast cell lines from both patients for the demonstration of alpha and beta locus messenger RNA showed no difference between patients and control. These patients have a rare form of adult-onset progressive motor neuron disease presumably due to abnormal beta subunits, causing severe deficiency of both Hex A and Hex B. The phenotypic expression of this disease is similar to motor neuron disease due to alpha locus mutations, which suggests that the Hex A deficiency, even though only a partial one, may be the important pathogenic factor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973515     DOI: 10.1016/0022-510x(88)90058-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Characterization of the mutant β-subunit of β-hexosaminidase for dimer formation responsible for the adult form of Sandhoff disease with the motor neuron disease phenotype.

Authors:  Kenichiro Yamada; Yuhei Takado; Yusuke S Kato; Yasukazu Yamada; Hideaki Ishiguro; Nobuaki Wakamatsu
Journal:  J Biochem       Date:  2012-11-05       Impact factor: 3.387

Review 2.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

3.  A common beta hexosaminidase gene mutation in adult Sandhoff disease patients.

Authors:  M Gomez-Lira; A Sangalli; M Mottes; C Perusi; P F Pignatti; N Rizzuto; A Salviati
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

4.  Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.

Authors:  K Neote; B McInnes; D J Mahuran; R A Gravel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  P. Ala278Val mutation might cause a pathogenic defect in HEXB folding leading to the Sandhoff disease.

Authors:  Zahra Rahmani; Arsham Banisadr; Vadieh Ghodsinezhad; Mohsen Dibaj; Omid Aryani
Journal:  Metab Brain Dis       Date:  2022-10-03       Impact factor: 3.655

6.  An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds.

Authors:  B McInnes; M Potier; N Wakamatsu; S B Melancon; M H Klavins; S Tsuji; D J Mahuran
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.

Authors:  Michael B Tropak; Stephen P Reid; Marianne Guiral; Stephen G Withers; Don Mahuran
Journal:  J Biol Chem       Date:  2004-01-14       Impact factor: 5.157

8.  Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).

Authors:  H Schnorf; R Gitzelmann; N U Bosshard; M Spycher; W Waespe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

9.  Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry.

Authors:  Cees Bruggink; Ben J H M Poorthuis; André M Deelder; Manfred Wuhrer
Journal:  Anal Bioanal Chem       Date:  2012-04-20       Impact factor: 4.142

10.  Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency.

Authors:  Christopher Grunseich; Alice B Schindler; Ke-Lian Chen; Dara Bakar; Ami Mankodi; Ryan Traslavina; Abhik Ray-Chaudhury; Tanya J Lehky; Eva H Baker; Nicholas J Maragakis; Cynthia J Tifft; Kenneth H Fischbeck
Journal:  J Neurol       Date:  2015-03-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.